321 related articles for article (PubMed ID: 26862095)
1. Intraocular cytokines in retinal vein occlusion and its relation to the efficiency of anti-vascular endothelial growth factor therapy.
Shchuko AG; Zlobin IV; Iureva TN; Ostanin AA; Chernykh ER; Mikhalevich IM
Indian J Ophthalmol; 2015 Dec; 63(12):905-11. PubMed ID: 26862095
[TBL] [Abstract][Full Text] [Related]
2. Change of cytokines after intravitreal ranibizumab in patients with recurrent branch retinal vein occlusion and macular edema.
Noma H; Yasuda K; Shimura M
Eur J Ophthalmol; 2021 Jan; 31(1):204-210. PubMed ID: 31690095
[TBL] [Abstract][Full Text] [Related]
3. [Intraocular cytokines imbalance in retinal vein occlusion and its impact on the efficacy of anti-angiogenic therapy].
Shchuko AG; Zlobin IV; Yur'eva TN; Ostanin AA; Chernykh ER
Vestn Oftalmol; 2015; 131(2):50-58. PubMed ID: 26080583
[TBL] [Abstract][Full Text] [Related]
4. The correlation between cytokine levels in the aqueous humor and the prognostic value of anti-vascular endothelial growth factor therapy for treating macular edema resulting from retinal vein occlusion.
Yong H; Qi H; Yan H; Wu Q; Zuo L
Graefes Arch Clin Exp Ophthalmol; 2021 Nov; 259(11):3243-3250. PubMed ID: 34059950
[TBL] [Abstract][Full Text] [Related]
5. POSSIBLE MOLECULAR BASIS OF BEVACIZUMAB THERAPY FOR MACULAR EDEMA IN BRANCH RETINAL VEIN OCCLUSION.
Noma H; Mimura T; Yasuda K; Shimura M
Retina; 2016 Sep; 36(9):1718-25. PubMed ID: 26866529
[TBL] [Abstract][Full Text] [Related]
6. Intravitreal bevacizumab and cytokine levels in major and macular branch retinal vein occlusion.
Lim JW
Ophthalmologica; 2011; 225(3):150-4. PubMed ID: 21150231
[TBL] [Abstract][Full Text] [Related]
7. Association of aqueous humor cytokines with the development of retinal ischemia and recurrent macular edema in retinal vein occlusion.
Jung SH; Kim KA; Sohn SW; Yang SJ
Invest Ophthalmol Vis Sci; 2014 Apr; 55(4):2290-6. PubMed ID: 24398091
[TBL] [Abstract][Full Text] [Related]
8. AQUEOUS HUMOR CYTOKINES AND THERAPEUTIC CUSTOMIZATION IN NONRESPONDING MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION.
Modi A; Sharma K; Sudhakar NP; Yadav NK
Retin Cases Brief Rep; 2021 Mar; 15(2):127-130. PubMed ID: 30664079
[TBL] [Abstract][Full Text] [Related]
9. Functional-morphological parameters, aqueous flare and cytokines in macular oedema with branch retinal vein occlusion after ranibizumab.
Noma H; Mimura T; Yasuda K; Shimura M
Br J Ophthalmol; 2017 Feb; 101(2):180-185. PubMed ID: 27073207
[TBL] [Abstract][Full Text] [Related]
10. Changes in aqueous cytokines after intravitreal triamcinolone versus bevacizumab for macular oedema in branch retinal vein occlusion.
Sohn HJ; Han DH; Lee DY; Nam DH
Acta Ophthalmol; 2014 May; 92(3):e217-24. PubMed ID: 23889803
[TBL] [Abstract][Full Text] [Related]
11. Comparison of cytokine levels from undiluted vitreous of untreated patients with retinal vein occlusion.
Koss MJ; Pfister M; Rothweiler F; Michaelis M; Cinatl J; Schubert R; Koch FH
Acta Ophthalmol; 2012 Mar; 90(2):e98-e103. PubMed ID: 22066978
[TBL] [Abstract][Full Text] [Related]
12. Intraocular concentrations of growth factors and cytokines in retinal vein occlusion and the effect of therapy with bevacizumab.
Funk M; Kriechbaum K; Prager F; Benesch T; Georgopoulos M; Zlabinger GJ; Schmidt-Erfurth U
Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1025-32. PubMed ID: 19060280
[TBL] [Abstract][Full Text] [Related]
13. Role of Cytokines in Ranibizumab Therapy for Macular Edema in Patients with Central Retinal Vein Occlusion.
Matsushima R; Noma H; Yasuda K; Goto H; Shimura M
J Ocul Pharmacol Ther; 2019 Sep; 35(7):407-412. PubMed ID: 31373873
[No Abstract] [Full Text] [Related]
14. Reading speed improvements in retinal vein occlusion after ranibizumab treatment.
Suñer IJ; Bressler NM; Varma R; Lee P; Dolan CM; Ward J; Colman S; Rubio RG
JAMA Ophthalmol; 2013 Jul; 131(7):851-6. PubMed ID: 23699977
[TBL] [Abstract][Full Text] [Related]
15. Six-month changes in cytokine levels after intravitreal bevacizumab injection for diabetic macular oedema and macular oedema due to central retinal vein occlusion.
Wen J; Jiang Y; Zheng X; Zhou Y
Br J Ophthalmol; 2015 Oct; 99(10):1334-40. PubMed ID: 25841235
[TBL] [Abstract][Full Text] [Related]
16. Creation of Retinal Vein Occlusion Model in Cynomolgus Monkeys and Determination of its Pathological Features.
Inagaki S; Shimazawa M; Otsu W; Araki T; Numata Y; Nakamura S; Tsusaki H; Hara H
Curr Neurovasc Res; 2021; 18(1):123-133. PubMed ID: 32867658
[TBL] [Abstract][Full Text] [Related]
17. Effect of intravitreal dexamethasone implant on intra-ocular cytokines and chemokines in eyes with retinal vein occlusion.
Rezar-Dreindl S; Eibenberger K; Pollreisz A; Bühl W; Georgopoulos M; Krall C; Dunavölgyi R; Weigert G; Kroh ME; Schmidt-Erfurth U; Sacu S
Acta Ophthalmol; 2017 Mar; 95(2):e119-e127. PubMed ID: 27417275
[TBL] [Abstract][Full Text] [Related]
18. AQUEOUS HUMOR CYTOKINE LEVELS AND REBOUND MACULAR EDEMA AFTER CONBERCEPT TREATMENT IN PATIENTS WITH CENTRAL RETINAL VEIN OCCLUSION.
Yang KB; Sun XY; Sun LP; Li J; Liu ZL; Zhang H
Retina; 2021 Apr; 41(4):834-843. PubMed ID: 33755650
[TBL] [Abstract][Full Text] [Related]
19. Comparison of the Effect of Intravitreal Conbercept and Ranibizumab on Aqueous Humor Cytokines in Central Retinal Vein Occlusion-Related Macular Edema.
Cui W; Sun XY; Sun LP; Li J; Liu ZL; Zhang H
J Ocul Pharmacol Ther; 2021; 37(1):52-59. PubMed ID: 33216685
[No Abstract] [Full Text] [Related]
20. Effects of Intravitreal Ranibizumab Injection on Peripheral Retinal Microcirculation and Cytokines in Branch Retinal Vein Occlusion with Macular Edema.
Yasuda K; Noma H; Mimura T; Nonaka R; Sasaki S; Suganuma N; Shimura M
Medicina (Kaunas); 2023 May; 59(6):. PubMed ID: 37374257
[No Abstract] [Full Text] [Related]
[Next] [New Search]